A synthetic peptide for use as a blocking control in assays to test for specificity of LPL antibody, Alternative Names: LPL control peptide, LPL antibody Blocking Peptide, Anti-LPL Blocking Peptide, lipoprotein lipase Blocking Peptide, HDLCQ11 Blocking Peptide, LIPD Blocking Peptide
LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.